MONTRONI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 3.297
EU - Europa 1.692
AS - Asia 1.322
SA - Sud America 230
Continente sconosciuto - Info sul continente non disponibili 47
AF - Africa 37
OC - Oceania 8
Totale 6.633
Nazione #
US - Stati Uniti d'America 3.213
SG - Singapore 518
SE - Svezia 370
UA - Ucraina 289
VN - Vietnam 263
RU - Federazione Russa 234
CN - Cina 208
BR - Brasile 174
DE - Germania 166
IE - Irlanda 148
DK - Danimarca 101
HK - Hong Kong 98
IT - Italia 98
FR - Francia 96
GB - Regno Unito 75
FI - Finlandia 72
KR - Corea 66
TR - Turchia 66
CA - Canada 37
IN - India 21
AR - Argentina 16
BD - Bangladesh 16
BE - Belgio 15
ZA - Sudafrica 14
CO - Colombia 11
IQ - Iraq 11
CW - ???statistics.table.value.countryCode.CW??? 8
GT - Guatemala 8
MA - Marocco 8
HN - Honduras 7
MX - Messico 7
VE - Venezuela 7
CR - Costa Rica 6
EC - Ecuador 6
AT - Austria 5
CI - Costa d'Avorio 5
JO - Giordania 5
MY - Malesia 5
NL - Olanda 5
PL - Polonia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
KE - Kenya 4
NZ - Nuova Zelanda 4
PE - Perù 4
PY - Paraguay 4
SV - El Salvador 4
UZ - Uzbekistan 4
CL - Cile 3
EG - Egitto 3
GE - Georgia 3
IL - Israele 3
JP - Giappone 3
KZ - Kazakistan 3
LB - Libano 3
PH - Filippine 3
PK - Pakistan 3
PR - Porto Rico 3
RO - Romania 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
ES - Italia 2
GP - Guadalupe 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
TH - Thailandia 2
TW - Taiwan 2
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
ID - Indonesia 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
ME - Montenegro 1
MT - Malta 1
NI - Nicaragua 1
RS - Serbia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 6.594
Città #
Ashburn 373
Singapore 354
Chandler 347
Jacksonville 286
San Jose 174
Boardman 158
Dublin 147
Wilmington 143
Council Bluffs 133
Fairfield 120
Hong Kong 95
Dallas 91
Ho Chi Minh City 75
Seattle 73
Ann Arbor 70
Houston 68
San Mateo 66
Woodbridge 65
Beijing 62
Hanoi 58
Lawrence 58
Princeton 58
New York 55
Des Moines 53
Lauterbourg 50
Hefei 49
Los Angeles 49
The Dalles 49
Buffalo 32
Moscow 30
Harper Woods 29
San Diego 26
Cambridge 21
Brussels 15
Helsinki 15
Santa Clara 15
São Paulo 15
Phoenix 14
Da Nang 13
Orem 13
Chicago 11
Haiphong 11
Rome 10
Auburn Hills 9
Johannesburg 9
Seoul 9
Chelsea 8
Chennai 8
Milan 8
Washington 8
Ankara 7
Guatemala City 7
Norwalk 7
Willemstad 7
Bogotá 6
Montreal 6
Rio de Janeiro 6
San Francisco 6
San José 6
Stockholm 6
Thái Bình 6
Toronto 6
Abidjan 5
Amman 5
Denver 5
San Pedro Sula 5
Shanghai 5
Warsaw 5
Bến Tre 4
Cape Town 4
Charlotte 4
Hanover 4
Hải Dương 4
London 4
Nairobi 4
Nuremberg 4
Tashkent 4
Baghdad 3
Biên Hòa 3
Boston 3
Brasília 3
Brooklyn 3
Dhaka 3
Guangzhou 3
Karbala 3
Kuala Lumpur 3
Lima 3
Marche 3
Montevideo 3
Munich 3
Ninh Bình 3
Porto Alegre 3
Pune 3
Quanzhou 3
San Salvador 3
São João del Rei 3
Tbilisi 3
Tokyo 3
Torre Annunziata 3
Wuhan 3
Totale 3.919
Nome #
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 193
Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. 186
Anticardiolipin antibodies expression in psoriasis 181
Higly active antiretroviral therapy induces specific changes in effector and central memory T cell sub-populations 163
Diagnosi sierologica nelle malattie autoimmuni non organo-specifiche. 154
Diagnosis of Immediate-Type ß-Lactam Allergy In Vitro by Flow-Cytometric Basophil Activation Test and Sulfi doleukotriene Production: a Multicenter Study. 148
Effects of cryopreservation on lymphocyte immunophenotype and function 145
Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy. 145
Exogenous IL-2 administration corrects the cell cycle perturbation of lymphocytes from HIV-infected individuals 142
Comparsa di polmonite in soggetto con storia recente di inappetenza, disfagia, calo ponderale, ed eritema diffuso. 141
Abnormal intracellular kinetics of cell –cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: a novel biological link between immune activation, accelerated T- cell turnover and high levels of apoptosis 138
Triple nucleoside treatment with abacavir plus the lamivudine/zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults; results of a 48-week open-label, equivalence trial (CAN 3014) 135
Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? 132
High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome. 132
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART. 131
Interruption of antiretroviral therapy is associated with increased plasma cystatin C. 130
Il ruolo del Medico di Medicina Generale nella diagnosi precoce della malattia da HIV. 129
Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. 126
Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naïve for Antiretrovirals 125
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy. 122
Genotypic Resistance Tests for the Management of Structured Therapeutic Interruptions after Multiple Drug Failure: Prosecution 121
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. 120
I vaccini, da Jenner ai vaccini a DNA 115
Unscheduled cyclin B expression and p34 cdc2 activation in T-lymphocytes from HIV patients 113
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. 113
Major clinical outcomes in antiretroviral therapy (ART)-naïve participants and in those not receiving ART at baseline in the SMART study. 112
Specific changes in the post-translational regulation of nucleolin in lymphocytes from patients infected with human immunodeficiency virus 112
Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization. 112
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina. 111
Impact of Higly Active Antiretroviral Therapy on the Presenting Features and Outcome of Patients with Acquired Immunodeficiency Syndrome-Related Kaposi Sarcoma 108
Lo studio fenotipico delle cellule mononucleate, linee guida all'impiego clinico, alla lettura ed all'interpretazione nelle diverse condizioni morbose. 107
HIV-induced abnormalities in myelopoiesis and their recovery following antiretroviral therapy 107
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. 106
Sexual behaviour of heterosexual individuals with HIV infection naïve for antiretroviral therapy in Italy . 104
Lo studio fenotipico di linfociti e altre cellule mononucleate. 103
Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replicatio 102
Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status 102
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. 102
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis. 100
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. 100
Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures. 98
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 98
Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients. 97
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients. 96
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. 96
Loss of CD127 (Interleukin-7 receptor) expression defines an expansion of “effector memory” CD8+Tcells in HIV-infected patients 95
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis. 94
Il paziente adulto con immunodeficienza. 90
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina. 90
Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from tha italian cohort of antiretroviral-naïve patients study 90
Low prevalence of primary mutations associated with drug resistance in antiviral-naïve patients at therapy initiation 88
Identikit della immunodeficienza da HIV. 81
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up. 81
Il ruolo del Mmg nella diagnosi precoce della malattia da HIV. 80
Infezione da HIV-1. 79
La diagnosi immunologica delle Malattie Autoimmuni non Organo Specifiche 71
Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the I.Co.N.A study 71
L’immunoricostituzione, un paesaggio dai mutevoli confini 70
Totale 6.633
Categoria #
all - tutte 27.230
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.230


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022269 0 0 0 0 8 21 8 43 26 56 23 84
2022/2023948 88 72 67 95 104 173 0 65 235 1 24 24
2023/2024404 85 11 17 73 70 62 8 8 0 4 12 54
2024/2025688 49 66 44 4 11 43 31 15 204 34 53 134
2025/20261.855 86 121 53 166 274 161 390 211 146 158 45 44
2026/2027610 46 124 126 311 3 0 0 0 0 0 0 0
Totale 6.633